Literature DB >> 7011832

Oral acetylcysteine in cystic fibrosis. A co-operative study.

M Götz, R Kraemer, K F Kerrebijn, C Popow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7011832

Source DB:  PubMed          Journal:  Eur J Respir Dis Suppl        ISSN： 0106-4347


× No keyword cloud information.
  7 in total

Review 1.  Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.

Authors:  Julian Tam; Edward F Nash; Felix Ratjen; Elizabeth Tullis; Anne Stephenson
Journal:  Cochrane Database Syst Rev       Date:  2013-07-12

Review 2.  Interventions for treating distal intestinal obstruction syndrome (DIOS) in cystic fibrosis.

Authors:  Francis J Gilchrist; Jessica Green; Will Carroll
Journal:  Cochrane Database Syst Rev       Date:  2021-12-22

Review 3.  Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis.

Authors:  Will Carroll; Jessica Green; Francis J Gilchrist
Journal:  Cochrane Database Syst Rev       Date:  2021-12-22

4.  A double-blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosis.

Authors:  F Ratjen; R Wönne; H G Posselt; B Stöver; D Hofmann; S W Bender
Journal:  Eur J Pediatr       Date:  1985-11       Impact factor: 3.183

Review 5.  Interventions for treating distal intestinal obstruction syndrome (DIOS) in cystic fibrosis.

Authors:  Jessica Green; Will Carroll; Francis J Gilchrist
Journal:  Cochrane Database Syst Rev       Date:  2018-08-03

Review 6.  Antioxidant supplementation for lung disease in cystic fibrosis.

Authors:  Oana Ciofu; Sherie Smith; Jens Lykkesfeldt
Journal:  Cochrane Database Syst Rev       Date:  2019-10-03

Review 7.  Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis.

Authors:  Jessica Green; Francis J Gilchrist; Will Carroll
Journal:  Cochrane Database Syst Rev       Date:  2018-06-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.